| Model Number |
M0065051600 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Hematuria (2558); Swelling/ Edema (4577)
|
| Date of Event |
01/10/2020
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Block b3: the exact event onset date is unknown.The provided event date of (b)(6) 2020, was chosen as the best estimate based on the procedure which happened sometime in 2020 and nine (9) days post-procedure (pod09) ed presentation for hematuria and lle.Blocks d4, h4: the complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.Block h6: patient code e2338 captures the reportable event of lower limb edema.Patient code e1302 captures the reportable event of hematuria.Impact code f12 captures the reportable event of serious injury.
|
| |
|
Event or Problem Description
|
|
It was reported to boston scientific corporation that a piranha biopsy forceps was used during a cystourethroscopy with ureteroscopy and pyeloscopy and fulguration of ureteral lesion procedure performed sometime in 2020.During the procedure, the acquisition of the biopsy specimen was adequate.Nine (9) days post-procedure (pod09) the patient presented to the emergency department (ed) for hematuria and lower limb edema (lle).Computed tomography arterial portography (ctap) found no evidence of pelvic thrombus and with evidence of prostate cancer with metastatic lymphadenopathy.Lle doppler revealed no evidence of deep vein thrombosis (dvt).The patient was discharged from the ed without admission.Per physician's assessment, the event was not serious, was possibly related to the device, and probably related to the procedure.
|
| |
|
Event or Problem Description
|
|
It was reported that a piranha biopsy forceps was used during a cystourethroscopy with ureteroscopy and pyeloscopy and fulguration of ureteral lesion procedure performed sometime in 2020.During the procedure, the acquisition of the biopsy specimen was adequate.Nine (9) days post-procedure (pod09) the patient presented to the emergency department (ed) for hematuria and lower limb edema (lle).Computed tomography arterial portography (ctap) found no evidence of pelvic thrombus and with evidence of prostate cancer with metastatic lymphadenopathy.Lle doppler revealed no evidence of deep vein thrombosis (dvt).The patient was discharged from the ed without admission.Per physician's assessment, the event of hematuria was not serious, was possibly related to the device, and causally related to the procedure.The event of lle, was not serious, was possibly related to the device and probably related to the procedure.
|
| |
|
Additional Manufacturer Narrative
|
|
Block h11: blocks a3b, b5, h2, and h11 have been updated based on the additional information received on may 28, 2024.Block b3: the exact event onset date is unknown.The provided event date of january 10, 2020, was chosen as the best estimate based on the procedure which happened sometime in 2020 and nine (9) days post-procedure (pod09) ed presentation for hematuria and lle.Blocks d4, h4: the complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.Block h6: patient code e2338 captures the reportable event of lower limb edema.Patient code e1302 captures the reportable event of hematuria.Impact code f12 captures the reportable event of serious injury.
|
| |
|
Search Alerts/Recalls
|